Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2017 | |
| Cash Flows From Operating Activities | |
| Net Income | -26,970 |
| Other Working Capital | 850 |
| Other Operating Activity | 870 |
| Operating Cash Flow | $-25,250 |
| Cash Flows From Investing Activities | |
| Investing Cash Flow | $0 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 30,020 |
| Financing Cash Flow | $30,020 |
| End Cash Position | 4,760 |
| Net Cash Flow | $4,760 |
| Free Cash Flow | |
| Operating Cash Flow | -25,250 |
| Free Cash Flow | -25,250 |